These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15261447)

  • 1. Malignant mesothelioma--the UK experience.
    O'Brien ME
    Lung Cancer; 2004 Aug; 45 Suppl 1():S133-5. PubMed ID: 15261447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MVP and vinorelbine for malignant pleural mesothelioma.
    Mordant P; Loriot Y; Soria JC; Deutsch E
    Lancet; 2008 Aug; 372(9639):629; author reply 629-30. PubMed ID: 18722865
    [No Abstract]   [Full Text] [Related]  

  • 3. BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112.
    Muers MF; Rudd RM; O'Brien ME; Qian W; Hodson A; Parmar MK; Girling DJ;
    Thorax; 2004 Feb; 59(2):144-8. PubMed ID: 14760156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.
    Girling DJ; Muers MF; Qian W; Lobban D
    Semin Oncol; 2002 Feb; 29(1):97-101. PubMed ID: 11836674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial.
    O'Brien ME; Watkins D; Ryan C; Priest K; Corbishley C; Norton A; Ashley S; Rowell N; Sayer R
    Ann Oncol; 2006 Feb; 17(2):270-5. PubMed ID: 16317014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.
    Baas P
    Semin Oncol; 2002 Feb; 29(1):62-9. PubMed ID: 11836670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
    Muers MF; Stephens RJ; Fisher P; Darlison L; Higgs CM; Lowry E; Nicholson AG; O'Brien M; Peake M; Rudd R; Snee M; Steele J; Girling DJ; Nankivell M; Pugh C; Parmar MK;
    Lancet; 2008 May; 371(9625):1685-94. PubMed ID: 18486741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
    Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
    Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice.
    Cordony A; Le Reun C; Smala A; Symanowski JT; Watkins J
    Value Health; 2008; 11(1):4-12. PubMed ID: 18237355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.
    Fennell DA; Parmar A; Shamash J; Evans MT; Sheaff MT; Sylvester R; Dhaliwal K; Gower N; Steele J; Rudd R
    J Clin Oncol; 2005 Jan; 23(1):184-9. PubMed ID: 15625372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma.
    Mendes R; O'Brien ME; Mitra A; Norton A; Gregory RK; Padhani AR; Bromelow KV; Winkley AR; Ashley S; Smith IE; Souberbielle BE
    Br J Cancer; 2002 Feb; 86(3):336-41. PubMed ID: 11875694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.
    Middleton GW; Smith IE; O'Brien ME; Norton A; Hickish T; Priest K; Spencer L; Ashley S
    Ann Oncol; 1998 Mar; 9(3):269-73. PubMed ID: 9602260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
    Vokes EE
    Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.
    Evans WK
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 4):18-25; discussion 25-6. PubMed ID: 9556779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
    J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.